Ziviba

Ziviba combines ezetimibe and rosuvastatin to support cholesterol management. This oral medication targets LDL cholesterol and triglycerides for cardiovascular health. Ideal for adults managing lipid levels with a single daily dose. A trusted option in cholesterol treatment regimens.

Ziviba is used to lower high cholesterol and triglycerides when diet and lifestyle changes are insufficient. Ezetimibe reduces cholesterol absorption in the intestines, while rosuvastatin decreases cholesterol production in the liver. Together, they help manage lipid levels to reduce cardiovascular risk. This combination is often prescribed for patients with primary hyperlipidemia or mixed dyslipidemia.

Ziviba may help reduce LDL cholesterol and increase HDL cholesterol over time. Some users notice improved energy levels as lipid profiles stabilize. Regular use supports overall cardiovascular health by maintaining balanced cholesterol levels. Individual responses vary based on diet, exercise, and metabolism.

Store Ziviba at room temperature away from moisture and heat. Keep out of reach of children and pets. Avoid crushing or splitting tablets unless directed by a healthcare professional. Report any unusual muscle pain or weakness to a doctor promptly. Pregnant or breastfeeding individuals should consult a healthcare provider before use.

Ziviba may interact with other cholesterol-lowering drugs, blood thinners, or medications metabolized by the liver. Grapefruit juice could affect rosuvastatin levels; moderation is advised. Alcohol use may increase the risk of liver-related side effects. Always inform your healthcare provider about all medications and supplements you take.